Finance

Lists
Why is ORCHPHARMA down २.१४%?
Dive Deeper
ORCHPHARMA:NSE
Orchid Pharma Ltd
₹ ९२५.००
-२.१४%
(-२०.२५) 1D
अक्टोबर १५, १५:३०:०० GMT+५:३०  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ORCHPHARMA...
Open
₹ ९४५.२५
High
₹ ९५०.२५
Low
₹ ९२५.००
Mkt. cap
५५.३९ अरब
Avg. vol.
१.०७ लाख
Volume
४२.५६ हजार
52-wk high
₹ १,१४३.५०
52-wk low
₹ ४८०.००
EPS
-₹ ०.८८
No. of employees
१ हजार
Open
₹ ९४५.२५
High
₹ ९५०.२५
Low
₹ ९२५.००
Mkt. cap
५५.३९ अरब
Avg. vol.
१.०७ लाख
Volume
४२.५६ हजार
52-wk high
₹ १,१४३.५०
52-wk low
₹ ४८०.००
EPS
-₹ ०.८८
No. of employees
१ हजार
News stories
From web sources and news partners
The Seattle Times
The Seattle Times
·
४४ मिनेट पहिले
Wall Street steadies following jarring drops for AI stocks worldwide
MarketBeat
MarketBeat
·
१२ मिनेट पहिले
Pool (NASDAQ:POOL) Stock Jumps 7.4% - Time to Buy?
Reuters
Reuters
·
२ घण्टा पहिले
Nasdaq reports network disruption, US equities data feeds impacted
Profile
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai. It was founded by Kailasam Raghavendra Rao on 1 July 1992. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
About Orchid Pharma Ltd
CEO-
Employees१.१७ हजार
Founded१९९२
Headquarters-
Sector-
Last report
२०२६ अगस्ट २१
Fiscal period
Q1 2027
₹ ०.५४ / ₹ ३.६०
-८५.००%miss
Revenue / Est. (INR)
३.०४ अरब / २.३० अरब
+३१.९६%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.९४ अरब
२.०७ अरब
६.५९ अरब
३.०४ अरब
Cost of goods sold
१.३३ अरब
१.४३ अरब
५.०३ अरब
२.०४ अरब
Cost of revenue
१.३३ अरब
१.४३ अरब
५.०३ अरब
२.०४ अरब
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२४.८५ करोड
२४.१३ करोड
५०.२३ करोड
२८.०४ करोड
Operating expense
७१.३९ करोड
७१.५९ करोड
१.४० अरब
९६.८२ करोड
Total operating expenses
२.०४ अरब
२.१५ अरब
६.४३ अरब
३.०१ अरब
Operating income
-१०.३८ करोड
-७.४७ करोड
१६.३८ करोड
३.०५ करोड
Other non operating income
१०.७७ करोड
५.६१ करोड
-२३.८० करोड
१.८३ करोड
EBT including unusual items
-५.७२ करोड
-१२.६१ करोड
१३.१९ करोड
३.३० करोड
EBT excluding unusual items
-५.७२ करोड
-५.५० करोड
५.४९ करोड
३.३० करोड
Income tax expense
-
-
१७.०० हजार
७.२३ लाख
Effective tax rate
-
-
०.०१%
२.१९%
Other operating expenses
३७.६४ करोड
३८.४३ करोड
४१.९३ करोड
५७.८३ करोड
Net income
-५.७२ करोड
-१२.६१ करोड
१३.१९ करोड
३.२२ करोड
Net profit margin
-२.९६%
-६.०९%
२.००%
१.०६%
Earnings per share
-१.१३
-१.०८
४.५८
०.५४
Interest and investment income
-
-
१०.१२ करोड
-
Interest expense
-३.७३ करोड
-३.१८ करोड
-
-२.२३ करोड
Net interest expenses
-३.७३ करोड
-३.१८ करोड
१०.१२ करोड
-२.२३ करोड
Depreciation and amortization charges
८.९० करोड
९.०३ करोड
१६.६६ करोड
१०.९५ करोड
EBITDA
-१.६० करोड
१.०५ करोड
२६.९६ करोड
११.९१ करोड
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू